This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated DSC2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-DSC2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~100 kDa | |
| Observed band | ~110 kDa | |
| Gel | 10% (catalog A03205-2) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Glycosylated + Phosphorylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 2 isoform(s) |
The A03205-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human Hela, human HepG2, rat heart (catalog A03205-2) |
| Gel % | 10% (catalog A03205-2) |
| Load | 30 ug; reducing conditions (catalog A03205-2) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A03205-2) |
| Membrane | nitrocellulose membrane (catalog A03205-2) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A03205-2) |
| Primary antibody | A03205-2 · 1:1000 (catalog A03205-2) |
| Primary incubation | overnight at 4°C (catalog A03205-2) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A03205-2) |
| Secondary incubation | 1.5 hour at RT (catalog A03205-2) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A03205-2) |
| Detection | ECL (catalog A03205-2) |
DSC2 is predicted at 100 kDa, while an empirical band appears at ~110 kDa; the cause of that difference is not established.
| Band at ~110 kDa | Empirical DSC2 band reported in reducing whole-cell and tissue lysates; confirm identity with appropriate controls. |
| Band near 100 kDa | Near the predicted mass of the 901-residue precursor; identity requires confirmation. |
| Band below the precursor region | Signal-peptide and propeptide cleavage could reduce sequence mass; mature-band migration is not supplied. |
| Possible doublet or multiple bands | Isoforms 2A and 2B or processing could contribute; distinct migration is not established. |
| Broad signal near the DSC2 band | Variation at N-linked glycosylation sites is possible, but a smear is not established by the site annotations. |
| Predicted precursor mass | The 901-residue sequence has a predicted mass of 100 kDa; the reported empirical band is ~110 kDa. |
| N-linked glycosylation at Asn34, Asn166, Asn392, Asn546 and Asn629 | May alter apparent migration; Asn392 is annotated with a complex glycan, but the contribution to the observed band is unknown. |
| Signal peptide at residues 1–27 and propeptide at residues 28–135 | Cleavage reduces sequence mass relative to the precursor; mature-band migration is not supplied. |
| Splice isoforms 2A and 2B | May differ in apparent size, but their relative order and separation are not established. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | DSC2 is a cell-membrane and desmosomal protein that may be poorly recovered in a whole-cell preparation. | Check membrane-protein recovery and a DSC2-positive lysate. |
| Band higher than expected | The reported ~110 kDa band exceeds the 100 kDa predicted precursor mass; the cause is unestablished. | Compare with the reported band and confirm identity using a second antibody or DSC2 depletion. |
| Band lower than expected | Signal-peptide or propeptide cleavage could reduce sequence mass. | Check the antibody epitope and confirm the lower band's identity with an independent antibody or DSC2 depletion. |
| Broad smear instead of sharp band | Variable N-linked glycosylation is possible at the annotated sites, but is not demonstrated as the cause. | Compare matched samples with and without N-glycan removal and confirm DSC2 identity. |
| Multiple bands | Isoforms 2A and 2B or precursor processing could contribute; distinct bands are not established. | Check antibody epitope coverage and compare bands after DSC2 depletion. |
| Weak or no signal | Low recovery of membrane-associated DSC2 is possible. | Check extraction and loading with a membrane-protein control and a DSC2-positive sample. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Endometrium | glandular cells | High | Protein (IHC) | HPA → |
| Esophagus | squamous epithelial cells | High | Protein (IHC) | HPA → |
| Heart muscle | cardiomyocytes | High | Protein (IHC) | HPA → |
| Oral mucosa | squamous epithelial cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Caudate | glial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for DSC2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-DSC2 antibody, A03205-2, with a Western blot image from human HeLa and HepG2 cells and rat and mouse heart lysates. The reported band is approximately 110 kDa versus an expected 100 kDa; evidence is limited to these shown samples and conditions.
Which to pick: A03205-2 is the only listed option. It reports human, mouse and rat reactivity and has a Western blot image. Use the shown sample contexts and 1:1000 primary antibody dilution as a starting point for your experiment.